NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Inceptor Bio

Inceptor Bio

Private
Morrisville, North CarolinaHealthcare & Life Scienceshttps://inceptor.bio/

Last Round

Series A

Extension

Feb 25, 2025

Total Funding Raised

$84M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Inceptor Bio is a biotechnology company that develops next-generation cell and gene therapies to treat difficult-to-treat cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cell therapyCAR-Tsolid tumorgene therapyCAR-MNK cell therapybiotech platformclinical stage biotechGMP manufacturingcancer immunotherapynext-gen CAR-Tbiotech incubatoroncology pipelinecell engineeringimmuno-oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inceptor Bio Comparables

Compare Inceptor Bio with similar companies based on industry and business-model similarity.

Inceptor Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Link Cell Therapies
88%
Currus Biologics
86%
Leucid Bio
85%

Inceptor Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionFeb 25, 2025
Series AMay 19, 2022
SeedJun 14, 2021

Key People

Founding team and executive leadership

Matthias Schroff

Chief Executive Officer

Executive Team

Inceptor Bio Investors

Notable investors and investment history

Inceptor Bio investors
InvestorRounds
Kineticos VenturesSeries A, Seed, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 71% MoM, reaching 3.5K.

Inceptor Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inceptor Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inceptor Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersMorrisville, North Carolina
Employee Range21
Year Founded2020
Last FundingFeb 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.